Schematic view of intracellular signaling cascades triggered by receptor tyrosine kinase in Schwann cells. Schematic view of intracellular signaling cascades.

Slides:



Advertisements
Similar presentations
Cell Communication Chapter 11. Types of Cell Signaling  Local Regulators – molecules released travel short distances to other cells in the area  Examples:
Advertisements

Chapter  Differentiate between the following:  Paracrine  Endocrine  Autocrine.
Signal transduction. General scheme There are two general types of receptors: cell-surface and intracellular receptors.
Trafficking-dependent and -independent modes of serotonin transporter regulation Depicted are 2 recently elaborated pathways that appear to establish appropriate.
signal transduction Cell-cell contact
Chapter 11 – Cell Communication
SIGNAL TRANSDUCTION Signal Transduction Pathway Protein Modification Phosphorylation Cascade Protein Kinases.
Concept 4: Analyzing Cell Communication
Innate immune-signaling cascades and evidence for upregulation in brain following AIE exposure. Innate immune-signaling cascades and evidence for upregulation.
Connecting COX-2 and Wnt in cancer
Figure 4 Simplified T cell and antigen presenting
Juvenile Myelomonocytic Leukemia
BRAF inhibitor: targeted therapy in hairy cell leukemia
HER2/HER3 heterodimers in prostate cancer
Cell Communication (1.4) – Part 1
Small-molecule inhibitor QLT-0267 suppresses ILK activity and inhibits its downstream signaling. Small-molecule inhibitor QLT-0267 suppresses ILK activity.
Figure 4 Possible combination therapies CDK4/6 inhibitors
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Cell Communication.
Figure 1 A schematic representation of the HER2 signalling pathway
Figure 3 Defects in the T cell receptor signalling pathway
by Walter Zumkeller, and Stefan Burdach
Figure 2 Oestrogen receptor signalling pathways
Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Endocrinol. doi: /nrendo
Schematic representation of main EGFR-TKIs resistance mechanisms.
Nat. Rev. Nephrol. doi: /nrneph
Gonadotropin Signaling in the Ovary
A genome-based strategy uncovers frequent BRAF mutations in melanoma
The chimeric Trk protein, composed by the TK domain with ATPase activity and a TM loop along with a fusion partner. The chimeric Trk protein, composed.
Apoptosis-targeted therapies for cancer
Adrenergic and Cholinergic Control in the Biology of Epidermis: Physiological and Clinical Significance  Sergei A. Grando, Mark R. Pittelkow, Karin U.
Figure 1 The VEGF family of growth factors
The Hypoxic Response: Huffing and HIFing
Defective neutrophil rolling and transmigration in acute uremia
Heather C. Etchevers  Journal of Investigative Dermatology 
Cell Communication (Signaling) Part 3
Cell Communication (1.4) – Part 1
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus  John E. Gerich, MD  Mayo Clinic Proceedings 
Apoptosis-targeted therapies for cancer
Cell Communication (Signaling) Part 3
Platelet-derived growth factor (PDGF) signalling pathway.
Proposed model of how USP2a-driven microRNA deregulation enhances MYC protein expression through impairment of the MDM2–p53 pathway. p53 regulates miR-34b/c.
Proposed model of signalling pathways involved in RBC shrinkage and vesiculation Inhibition of the depicted kinases induces shrinkage and vesiculation.
Components and outcomes of selected TNF-superfamily signalling pathways. Components and outcomes of selected TNF-superfamily signalling pathways. (Left)
The new kid on the block(ade) of the IGF-1 receptor
Volume 1, Issue 3, Pages (April 2002)
Proposed encoding of VLS MSNs
Friends with Benefits: Microenvironmental NRG1β and HGF Mediate HER2-Targeted Resistance in L-HER2+ and HER2E Breast Cancer  Sarah B. Crist, Cyrus M.
Schematic representation of signaling by KSHV LANA
Signaling by Ras/Raf/ERK in the regulation of β-cell proliferation.
The rudimentary human β-cell mitogenic signaling road map.
Novel aspects of complement in kidney injury
A suggested model for the role of CPPED1 in glucose metabolism.
Schematic of mGluRI-NMDAR signaling chains: Homer-mediated (white element titles) and G-protein-mediated (black element titles). Schematic of mGluRI-NMDAR.
Yiannis S. Chatzizisis et al. JACC 2007;49:
A schematic representation of NOTCH signaling through DAB1–ABL–TRIO–RHO that stimulates colorectal cancer invasion and metastasis. A schematic representation.
Activation of Wnt signaling pathway in trastuzumab-resistant cell lines. Activation of Wnt signaling pathway in trastuzumab-resistant cell lines. A, bar.
Radiation does not alter AKT and MTOR gene expression.
The critical roles of miR-23a and miR-27a in colorectal cancer progression. miR-23a primarily increases cell motility through downregulation of its target.
Schematic representation of signaling pathways associated with cannabinoid receptor activation induced by its agonists. Schematic representation of signaling.
HER2 and PI3K-targeted therapies result in FOXO3a-mediated feedback upregulation of HER3 and IGF1R and provide an escape from PI3K pathway inhibition.
Robert Morey, Louise C. Laurent  Cell Stem Cell 
Skp2, the FoxO1 hunter Cancer Cell
IPA depicting predicted activation of cannabinoid receptor (CNR1) and estrogen receptor (ESR) pathways in acutely and persistently infected cells at PST-0.
A schematic diagram showing the mechanism by which L5 triggers platelet activation and aggregation. A schematic diagram showing the mechanism by which.
Tackling Resistance to PI3K Inhibition by Targeting the Epigenome
Toll-like receptors, adapter proteins, and signaling molecules.
Presentation transcript:

Schematic view of intracellular signaling cascades triggered by receptor tyrosine kinase in Schwann cells. Schematic view of intracellular signaling cascades triggered by receptor tyrosine kinase in Schwann cells. We propose that upregulation of MAG mRNA implies a transition from immature Schwann cell to the promyelinating state and that myelination will subsequently occur. Activation of both cAMP and Akt-GSK-3β signals and, at the same time, downregulation of MAPK are all required for MAG expression. At present, the targets of these three pathways are not known. Toru Ogata et al. J. Neurosci. 2004;24:6724-6732 ©2004 by Society for Neuroscience